ArticlePloS one2026
Innate immunogenetic synergy between KIR and Neanderthal-derived OAS variants predicts COVID-19 outcomes.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGenetic factors modulate the progression of coronavirus disease 2019 (COVID-19), but interactions between innate immune gene variants remain incompletely understood. Prior work identified Killer Immunoglobulin-like Receptor (KIR) genotypes and Neanderthal-introgressed OAS1/2/3 haplotypes as key modulators of disease severity. Given these parallel findings, we aimed to evaluate the synergistic impact of KIR motifs, Neanderthal-inherited OAS1/2/3 variants, and other immune-related SNPs on COVID-19 symptomatology and severity.
methodsIn a cohort of 175 unvaccinated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals (65 asymptomatic, 47 mild-intermediate, 63 severe), we genotyped KIR/KIR-ligand motifs and variants in OAS1/2/3, IFITM3, DPP4, TLR7, and APOE. Multivariate logistic regression models assessed independent and interactive predictors of symptomatic and severe disease, and ROC curve analysis was performed to quantify their discriminative ability.
resultsAn interaction between the absence of both the protective tAB1/wL KIR motif and the Neanderthal-derived OAS1/2/3 alleles significantly predicted symptomatic infection (OR 3.47, P = 0.006) and severe disease (OR 2.41, P = 0.038), achieving overall classification accuracies of 75.4% and 78.9%, respectively. Independent predictors included age, male gender, rs12252 (IFITM3) and rs3788979 (DPP4) as risk factors, and blood group A and APOE ε3ε3 status as protective factors. No rare TLR7 variants were detected.
conclusionThis study identifies, for the first time, a synergistic interaction between KIR motifs and Neanderthal-derived OAS1/2/3 variants influencing COVID-19 outcomes. These findings highlight the interplay between ancient and modern innate immune adaptations in shaping viral disease susceptibility. Future studies in larger and diverse populations are warranted to validate these immunogenetic interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.